OCC 1.33% 37.0¢ orthocell limited

Always tough to identify an inflexion point in advance,...

  1. 4,613 Posts.
    lightbulb Created with Sketch. 857
    Always tough to identify an inflexion point in advance, especially with a biotech but ultimately it comes down to sales and regulatory approvals.

    Last quarter sales were disappointing but all it takes is a quarter or two of significant growth and people are pretty quick to do the math on the compounding. Hopefully this quarter growth is sufficient to make the numbers look compelling.
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
37.0¢
Change
-0.005(1.33%)
Mkt cap ! $77.45M
Open High Low Value Volume
36.5¢ 37.0¢ 36.0¢ $35.00K 96.65K

Buyers (Bids)

No. Vol. Price($)
3 13501 36.0¢
 

Sellers (Offers)

Price($) Vol. No.
37.0¢ 2205 1
View Market Depth
Last trade - 16.10pm 14/06/2024 (20 minute delay) ?
Last
36.5¢
  Change
-0.005 ( 1.35 %)
Open High Low Volume
36.5¢ 37.0¢ 36.0¢ 50972
Last updated 15.44pm 14/06/2024 ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.